title: A practice-based approach to the 2012 position statement of the American Diabetes Association and the European Association for the Study of Diabetes.
abstract: The position statement on the management of hyperglycemia in patients with type 2 diabetes mellitus issued in 2012 by the American Diabetes Association and the European Association for the Study of Diabetes contains significant improvements over the 2009 version, including an emphasis on patient-centered care, enhanced strategies for lifestyle modification, a focus on comprehensive cardiovascular risk reduction, and increased pharmacotherapy choices. As diabetes management evolves over time, further improvements may be made in future consensus statements, including a focus on prevention and early treatment and improved glycemic control in all patients, including those with comorbidities. These goals will be achievable by waning use of therapies known to cause hypoglycemia and weight gain and the increased use of therapies that do not carry these risks.
authors.affiliation: Main Line Health System, Bryn Mawr, PA, USA. stschwar@gmail.com
authors.forename: Stanley S
authors.initials: SS
authors.lastname: Schwartz
mesh_terms: D002318:Cardiovascular Diseases / Q000628:therapy*; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000628:therapy*; D005260:Female; D006801:Humans; D006943:Hyperglycemia / Q000188:drug therapy* / Q000628:therapy*; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007674:Kidney Diseases / Q000628:therapy*; D008107:Liver Diseases / Q000628:therapy*; D008297:Male; D018802:Patient-Centered Care
chemical_list: D007004:Hypoglycemic Agents